-
Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
25 Apr 2024 07:49 GMT
Prostate cancer guidelines often recommend obtaining magnetic resonance imaging (MRI) before a biopsy, yet MRI … estimation vs MRI-based diagnostic approaches for prostate cancer screening.
To … 1.66]), and more indolent prostate cancers were detected (61 [1 …
-
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up.
25 Apr 2024 07:49 GMT
… primary curative radiation therapy for prostate cancer (PCa), as prospective studies with … in five fractions to the MRI-based target volume and 6 …
-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… conventional radiological methods (CT/MRI), and the cancer still responds … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
24 Apr 2024 08:24 GMT
… of active surveillance (AS) for prostate cancer is increasing, and racial disparities … -risk prostate cancer, with particular focus on the integration of multiparametric MRI (mpMRI … low- or favorable intermediate-risk prostate cancer. The odds of receiving AS …
-
Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18F-DCFPyL PSMA PET/CT With MRI.
25 Apr 2024 07:49 GMT
… on T2-weighted (T2W) MRI as an indication of … had urethral hyperintensity on T2W MRI, respectively (P < … PET imaging with T2W MRI can mitigate false-positive calls … gain traction in diagnosing localized prostate cancer.
Clinical nuclear medicine. 2024 …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… conventional radiological methods (CT/MRI), and the cancer still responds … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
What Prostate Cancer Screenings Involve
23 Apr 2024 13:32 GMT
… more likely to get prostate cancer.
Often, getting screened … Feng says.
What Prostate Cancer Screening Involves
Prostate cancer screening typically involves a … that guys get an MRI or biopsy of the … or genetic mutations for prostate cancer should be screened …
-
There Are Options to Consider When Monitoring for Prostate Cancer
23 Apr 2024 11:54 GMT
… with an aggressive form of prostate cancer. Treatment, in my case … likelihood of an aggressive prostate cancer is statistically unlikely for my … get a form of prostate cancer. Some less aggressive cancers … is a prostate-specific MRI scan available that, like …
-
Smart nanoprobe illuminates prostate cancer cells, reveals research
23 Apr 2024 00:23 GMT
… modalities such as magnetic resonance imaging (MRI) have revolutionized the … designed to infiltrate prostate tumors and send back … researchers used two prostate cancer cell lines exhibiting … men afflicted with prostate cancer,” explained Tatjana Atanasijevic …
-
New prostate cancer test to help avoid unnecessary biopsies
21 Apr 2024 10:40 GMT
… existing tests.
Multiparametric magnetic resonance imaging (mpMRI) is … of clinically significant prostate cancer, interpretation of the … without clinically significant prostate cancer by the new … African American. Because prostate cancer is more prevalent …